These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 3597148

  • 1. Radical radiation and oral and intra-vesical misonidazole for bladder cancer.
    Abratt RP, Barnes DR, Pontin AR, Sarembock LA, Williams AM.
    Int J Radiat Oncol Biol Phys; 1987 Jul; 13(7):1053-5. PubMed ID: 3597148
    [Abstract] [Full Text] [Related]

  • 2. A prospective randomised trial of radiation with or without oral and intravesical misonidazole for bladder cancer.
    Abratt RP, Craighead P, Reddi VB, Sarembock LA.
    Br J Cancer; 1991 Nov; 64(5):968-70. PubMed ID: 1931628
    [Abstract] [Full Text] [Related]

  • 3. Radical irradiation and misonidazole for T2 grade III and T3 bladder cancer: 2 year follow-up.
    Abratt RP, Barnes DR, Hammond JA, Sarembok LA, Tucker RD, Williams AM.
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1719-20. PubMed ID: 6384160
    [Abstract] [Full Text] [Related]

  • 4. Radical irradiation and misonidazole in the treatment of T2 grade III and T3 bladder cancer.
    Abratt RP, Sealy R, Tucker RD, Williams MA, Barnes DR, Johnson MB, Green JA, Cridland JS.
    Int J Radiat Oncol Biol Phys; 1983 May; 9(5):629-32. PubMed ID: 6853264
    [Abstract] [Full Text] [Related]

  • 5. The initial results in muscle-invading bladder cancer of RTOG 95-06: phase I/II trial of transurethral surgery plus radiation therapy with concurrent cisplatin and 5-fluorouracil followed by selective bladder preservation or cystectomy depending on the initial response.
    Kaufman DS, Winter KA, Shipley WU, Heney NM, Chetner MP, Souhami L, Zlotecki RA, Sause WT, True LD.
    Oncologist; 2000 May; 5(6):471-6. PubMed ID: 11110598
    [Abstract] [Full Text] [Related]

  • 6. Bladder cancer. The selection of patients for treatment by full-dose irradiation.
    Shipley WU, Rose MA.
    Cancer; 1985 May 01; 55(9 Suppl):2278-84. PubMed ID: 3919933
    [Abstract] [Full Text] [Related]

  • 7. Effect of misonidazole in preoperative irradiation for bladder cancer followed by total cystectomy.
    Ono K, Akuta K, Takahashi M, Abe M, Nishio Y, Okada K, Yoshida O.
    Radiat Med; 1989 May 01; 7(2):105-9. PubMed ID: 2508190
    [Abstract] [Full Text] [Related]

  • 8. Experience in the radical radiotherapy of cancer in the bilharzial bladder: the use of misonidazole.
    Awwad HK, Akhoush H, El-Merzabani M, El Badawy S, Barsoum M, el Baki HA.
    Radiother Oncol; 1984 Jun 01; 2(1):1-8. PubMed ID: 6095372
    [Abstract] [Full Text] [Related]

  • 9. Radical irradiation of T2 grade III and T3 bladder cancer--tumor response and prognosis.
    Abratt RP, Tucker RD, Barnes DR.
    Int J Radiat Oncol Biol Phys; 1983 Aug 01; 9(8):1213-5. PubMed ID: 6874452
    [Abstract] [Full Text] [Related]

  • 10. Concurrent cisplatin, 5-fluorouracil, leucovorin, and radiotherapy for invasive bladder cancer.
    Chen WC, Liaw CC, Chuang CK, Chen MF, Chen CS, Lin PY, Chang PL, Chu SH, Wu CT, Hong JH.
    Int J Radiat Oncol Biol Phys; 2003 Jul 01; 56(3):726-33. PubMed ID: 12788178
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L, Bladou F, Bardou VJ, Gravis G, Tallet A, Alzieu C, Serment G, Salem N.
    Urology; 2004 Sep 01; 64(3):488-93. PubMed ID: 15351577
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Combined modality program with possible organ preservation for invasive bladder carcinoma: results of RTOG protocol 85-12.
    Tester W, Porter A, Asbell S, Coughlin C, Heaney J, Krall J, Martz K, Venner P, Hammond E.
    Int J Radiat Oncol Biol Phys; 1993 Apr 02; 25(5):783-90. PubMed ID: 8478228
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Positive clinical experience with misonidazole in brachytherapy and external radiotherapy.
    Baillet F, Housset M, Dessard-Diana B, Boisserie G.
    Int J Radiat Oncol Biol Phys; 1989 Apr 02; 16(4):1073-5. PubMed ID: 2703387
    [Abstract] [Full Text] [Related]

  • 17. A randomised trial of accelerated radiotherapy for localised invasive bladder cancer.
    Horwich A, Dearnaley D, Huddart R, Graham J, Bessell E, Mason M, Bliss J.
    Radiother Oncol; 2005 Apr 02; 75(1):34-43. PubMed ID: 15878099
    [Abstract] [Full Text] [Related]

  • 18. Preliminary results of treatment of invasive bladder carcinoma with radiotherapy and cisplatin.
    Sauer R, Schrott KM, Dunst J, Thiel HJ, Hermanek P, Bornhof C.
    Int J Radiat Oncol Biol Phys; 1988 Oct 02; 15(4):871-5. PubMed ID: 3182327
    [Abstract] [Full Text] [Related]

  • 19. Radiotherapy with or without misonidazole for patients with stage IIIB or stage IVA squamous cell carcinoma of the uterine cervix: preliminary report of a Radiation Therapy Oncology Group randomized trial.
    Leibel S, Bauer M, Wasserman T, Marcial V, Rotman M, Hornback N, Cooper J, Gillespie B, Pakuris E, Conner N.
    Int J Radiat Oncol Biol Phys; 1987 Apr 02; 13(4):541-9. PubMed ID: 3104249
    [Abstract] [Full Text] [Related]

  • 20. Rapidly alternating chemotherapy and radiotherapy instead of cystectomy for the treatment of muscle-invasive carcinoma of the urinary bladder: long term results of a pilot study.
    Vikram B, Chadha M, Malamud SC, Hecht H, Grabstald H.
    Cancer; 1998 Mar 01; 82(5):918-22. PubMed ID: 9486582
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.